• <rp id="mz6wu"><meter id="mz6wu"></meter></rp><rp id="mz6wu"></rp>
  • <ruby id="mz6wu"><optgroup id="mz6wu"></optgroup></ruby><rt id="mz6wu"><meter id="mz6wu"></meter></rt>

    <cite id="mz6wu"><form id="mz6wu"></form></cite><video id="mz6wu"><menuitem id="mz6wu"><option id="mz6wu"></option></menuitem></video>
    <source id="mz6wu"><nav id="mz6wu"></nav></source>
  • <tt id="mz6wu"></tt>
    <tt id="mz6wu"><noscript id="mz6wu"><samp id="mz6wu"></samp></noscript></tt><tt id="mz6wu"><noscript id="mz6wu"><label id="mz6wu"></label></noscript></tt>
  • Image by Solera
    February 13, 2018 | By Solera

    Novartis Gains U.S. Approval For Glatopa For Multiple Sclerosis

    Novartis’s Sandoz division has won U.S. approval for a larger dose of its Glatops drug for multiple sclerosis (MS).

    Click Here to view the original article at Specialty Pharmacy Times

    A smaller focus to make a much larger impact. Our goal is to deliver on every promise we make

    Our Mission

    Learn More
    182tv